Marevan

Warfarin, the active ingredient in Marevan, is a vitamin K antagonist presented as an oral tablet for oral use. It is employed to prevent and treat thromboembolic disorders, including stroke in atrial fibrillation, deep‑vein thrombosis, and pulmonary embolism, in adult patients at risk of clot formation.

GNH USA supplies Marevan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions, including Europe, Asia and the Middle East.

Marevan (warfarin) acts on the coagulation cascade to reduce clot formation in several cardiovascular conditions. - Atrial fibrillation (stroke prophylaxis): Reduces the risk of ischemic stroke in patients with non‑valvular atrial fibrillation. - Deep‑vein thrombosis treatment: Facilitates clot resolution and prevents extension of lower‑limb venous thrombi. - Pulmonary embolism treatment: Helps dissolve emboli and lowers recurrence risk after an acute event. - General thromboembolic disorder prevention: Provides long‑term anticoagulation to avert new clot formation in at‑risk individuals.

Warfarin therapy is associated with a spectrum of adverse reactions, ranging from mild bleeding to life‑threatening events.

Common Side Effects: - Minor bleeding (e.g., gums, nosebleeds): Small amounts of bleeding that are usually self‑limiting. - Bruising: Easy bruising from minor trauma. - Headache: Persistent or intermittent headache. - Dizziness: Light‑headed sensation, especially when standing. - Gastrointestinal discomfort: Nausea, abdominal pain or dyspepsia.

Serious or Rare Side Effects: - Intracranial hemorrhage: Bleeding within the brain, a medical emergency. - Severe skin necrosis: Painful, purplish skin lesions that may progress to tissue death. - Allergic reactions: Rash, itching, or anaphylaxis in rare cases. - Hepatic dysfunction: Elevated liver enzymes indicating liver injury. - Massive gastrointestinal bleeding: Significant blood loss requiring urgent care.

When using Marevan, clinicians and patients should observe several safety measures to minimize bleeding risk and ensure effective anticoagulation. - Monitor INR regularly: Adjust dose to keep INR within the therapeutic range. - Assess liver function: Warfarin metabolism may be altered in hepatic impairment. - Avoid use in pregnancy: Warfarin is contraindicated due to teratogenic risk (Category X). - Review concomitant medications: Dose may need adjustment when interacting drugs are added or stopped. - Store at room temperature: Keep tablets in the original container, protect from moisture and direct sunlight.

Warfarin interacts with many medicines; some combinations must be avoided, while others require close monitoring.

Major Interactions (Avoid): - Amiodarone: Potentiates anticoagulant effect, increasing bleeding risk. - Azole antifungals (e.g., fluconazole, itraconazole): Strongly inhibit warfarin metabolism. - Rifampin and other enzyme inducers: Reduce warfarin levels, risking sub‑therapeutic anticoagulation. - High‑dose vitamin K supplements: Counteract warfarin’s action and may cause loss of anticoagulation.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): Additive bleeding tendency. - Certain antibiotics (e.g., trimethoprim‑sulfamethoxazole): May increase INR modestly. - Statins (e.g., simvastatin): Can modestly affect warfarin metabolism.